STOCK TITAN
  1. Home
  2. Sec-filings
  3. CGON
  4. [Form 4] CG Oncology, Inc. Common stock Insider Trading Activity

[Form 4] CG Oncology, Inc. Common stock Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock CGON logo
CG Oncology, Inc.

NASDAQ:CGON

CGON Rankings

#2057 Ranked by Market Cap
N/A Ranked by Dividends

CGON Latest News

Aug 29, 2025
CG Oncology’s Executive Leadership to Participate in Upcoming Investor Conferences
Aug 8, 2025
CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates
Jul 29, 2025
Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals
Jun 5, 2025
CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
May 15, 2025
CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

CGON Latest SEC Filings

Aug 8, 2025
[10-Q] CG Oncology, Inc. Common stock Quarterly Earnings Report
Aug 8, 2025
[8-K] CG Oncology, Inc. Common stock Reports Material Event
Aug 6, 2025
[Form 3] CG Oncology, Inc. Common stock Initial Statement of Beneficial Ownership
Aug 6, 2025
[SCHEDULE 13G] CG Oncology, Inc. Common stock SEC Filing
Jul 17, 2025
[144] CG Oncology, Inc. Common stock SEC Filing

CGON Stock Data

2.04B
69.49M
1.17%
112.44%
14.44%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
IRVINE